AI heart scanner could catch silent disease in thousands

NCT ID NCT07351656

Recruiting now Diagnosis Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether combining AI-powered electrocardiograms (ECGs) with focused heart ultrasound can effectively screen for heart disease in everyday community settings. Researchers at Mayo Clinic plan to enroll 19,300 people, including teens, adults, and pregnant women. The goal is to see how accurate and practical these tools are for detecting conditions like weak heart muscle, valve problems, and high blood pressure in the lungs, compared to standard tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-Enabled Electrocardiography and Focused Cardiac Ultrasound
What this could lead to: If successful, this could lead to a quick, accurate, and low-cost way to screen large populations for hidden heart disease, catching problems early.
What could go wrong: This is an early feasibility study, not a treatment trial. The AI may produce false positives or miss some conditions, and results may not apply to all groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART DISEASE

Contacts and locations

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.